March 2005

What’s New

January 2, 2008

HMP Launches Arthritis Practitioner HMP Communications is launching Arthritis Practitioner in May 2005. The publication will have editions in July, September, and November. The journal’s audience is comprised of more than 32,000 nurse practitioners and physician assistants that are profiled as high-prescribers of arthritis products and services. Arthritis Practitioner will deliver timely and practical advice […]

For Art’s Sake

January 2, 2008

Each month, this department pays homage to memorable advertising and marketing campaigns. The highlighted executions have been identified by leading creative executives for their noteworthy use of copy, art, photography, whimsy, uniqueness, etc. — in combination or as single branding elements. Creating good pharmaceutical advertising and marketing requires agencies to think out of the box […]

Global Perspective

January 2, 2008

Is Japan on the Verge of a Biotech Boom? A growing number of biopharma start-up companies are looking beyond the United States and Europe for business opportunities. And one market that is generating a lot of buzz in biotech today is Japan. One of the more under-reported business stories of the past year has been […]

E-Media

January 2, 2008

ISB and IBM launch Human Proteome Folding Project on World Community Grid The Institute for Systems Biology (ISB), in partnership with IBM, United Devices, and the University of Washington, has launched the Human Proteome Folding Project on World Community Grid. This project, the first to run on the grid, will help predict the shape of […]

Talent Pool

January 2, 2008

Pharma POOL Dr. Mahdi B. Fawzi Dr. Frank S. Walsh Wyeth Promotes Two Research Scientists to Executive VPs Wyeth Pharmaceuticals, Madison, N.J., a division of Wyeth, has promoted Mahdi B. Fawzi, Ph.D., to executive VP, head of preclinical development, and Frank S. Walsh, Ph.D., to executive VP, head of discovery research. Wyeth is one of […]

Letter from the Editor

January 2, 2008

Facing industry challenges Healthcare advertising agencies, service providers, and companies offering strategic consulting to pharmaceutical and life-sciences companies are grappling with the challenges facing their clients: shrinking profit margins, fewer drugs in the pipeline, consolidation, heightened regulatory scrutiny, and myriad other issues. A distinguished panel of agency presidents representing four leading healthcare communications and advertising […]

The Asthma Market Breathes Easier

January 2, 2008

The Asthma Market Breathes Easier The approach to treating asthma continues to evolve. Rescue bronchodilator therapies are giving way, both in medical practice and in the market, to prophylactic strategies, which include inhaled corticosteroids, long-acting beta2 agonists, and leukotriene antagonists. Sales of combination therapies, leukotriene antagonists, and the introduction of more expensive novel agents are […]

Dr. Mark Ahn — Poetic Science

January 2, 2008

Mark Ahn — Poetic Science For Mark Ahn, Ph.D., leadership is less about the power of one individual and more about the creation of heroic teams. Using a mix of literature, history, and traditional business skills, Dr. Ahn has found ways to unlock the imagination of his colleagues and employees at Hana Biosciences to build […]

Cautious Capital

January 2, 2008

The funding environment for biotech and start-up companies has improved considerably during the past few years. But venture capital investors are more cautious and more demanding than ever before. Karen Boezi Venture capital investors will increasingly be focused on capital efficiency and reducing risk. We believe this focus will continue to favor product companies over […]

What’s on Your Mind — Opinions

January 2, 2008

What’s on your Mind Opinions Monitoring Drug Safety The industry and the U.S. Food and Drug Administration have come under significant scrutiny since Merck’s withdrawal of Vioxx. Six papers on the issue were published on the subject in the Dec. 1, 2004, issue of the Journal of the American Medical Association. The journal’s editors called […]

PharmaTrax

January 2, 2008

Sales, Marketing, and R&D Trends from Industry Analysts Pharmaceutical Companies Rethink Consumer Marketing Strategies in 2005 Facing increased scrutiny from the federal government and the public, pharmaceutical companies are looking beyond direct-to-consumer (DTC) marketing to more effectively communicate the benefits and risks of their products. A recent study from Manhattan Research finds that more than […]

Confluence Marketing: A Union of Forces for a Shared Outcome

January 2, 2008

Confluence Marketing: A Union of Forces for a Shared Outcome Confluence marketing is a philosophy and a process for sharing ideas across key customer groups and breaking down traditional divides. It is precisely at the confluence of these groups that true marketing power is unleashed, and when the marketing agenda should be set. VIEW on […]

Making Metrics Matter — The Changing Paradigm of R&D Metrics

January 2, 2008

Making Metrics Matter The Changing Paradigm of R&D Metrics As the pharmaceutical industry comes under greater scrutiny across the board, everything from discovery processes to R&D productivity to profit margins is subject to review. In response, top industry executives are reexamining the efficiency of their R&D operations. In an effort to self-scrutinize, many companies are […]

Table of Contents

January 2, 2008

on the cover Making metrics matter: The changing paradigm of R&D metrics As the pharma industry comes under greater scrutiny, everything from discovery processes to R&D productivity to profit margins is subject to review. Metrics systems are being implemented to realize efficiencies and boost productivity. 8 FEATURES Cautious capital The funding environment for biotech and […]

FEEDBACK